Engineering Human Pluripotent Stem Cell Lines to Evade Xenogeneic Transplantation Barriers

Allogeneic human pluripotent stem cell (hPSC)-derived cells and tissues for therapeutic transplantation must necessarily overcome immunological rejection by the recipient. To define these barriers and to create cells capable of evading rejection for preclinical testing in immunocompetent mouse model...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizzato, Hannah A., Alonso-Guallart, Paula, Woods, James, Johannesson, Bjarki, Connelly, Jon P., Fehniger, Todd A., Atkinson, John P., Pruett-Miller, Shondra M., Monsma, Frederick J., Bhattacharya, Deepta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326974/
https://www.ncbi.nlm.nih.gov/pubmed/37425790
http://dx.doi.org/10.1101/2023.06.27.546594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326974/
https://www.ncbi.nlm.nih.gov/pubmed/37425790
http://dx.doi.org/10.1101/2023.06.27.546594

Ejemplares similares